Back to top
more

Clover Health Investments (CLOV)

(Delayed Data from NSDQ)

$5.00 USD

5.00
7,128,640

+0.20 (4.17%)

Updated Jun 18, 2026 03:59 PM ET

After-Market: $5.01 +0.01 (0.20%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (151 out of 247)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Retain CLOV Stock in Your Portfolio Now

by Zacks Equity Research

Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.

Zacks Equity Research

Why Is Clover Health Investments (CLOV) Down 11.6% Since Last Earnings Report?

by Zacks Equity Research

Clover Health Investments (CLOV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Fast-paced Mover Clover Health Investments (CLOV) Is a Great Choice for Value Investors

by Zacks Equity Research

Clover Health Investments (CLOV) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Equity Research

CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View

by Zacks Equity Research

Clover Health's Q3 sales soar 50%, but higher Insurance costs and a raised BER outlook weigh on investor sentiment.

Zacks Equity Research

Clover Health Investments, Corp. (CLOV) Reports Break-Even Earnings for Q3

by Zacks Equity Research

Clover Health Investments (CLOV) delivered earnings and revenue surprises of -100.00% and +4.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cigna Q3 Earnings Beat Estimates on Evernorth Health Unit Strength

by Zacks Equity Research

CI's Q3 earnings and revenues beat estimates as Evernorth Health Services powers growth despite healthcare headwinds.

Zacks Equity Research

Clover Health Investments (CLOV) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research

Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Is Clover Health Investments (CLOV) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Clover Health Investments, Corp. (CLOV) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.

Zacks Equity Research

Fast-paced Momentum Stock Clover Health Investments (CLOV) Is Still Trading at a Bargain

by Zacks Equity Research

Clover Health Investments (CLOV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Zacks Equity Research

Here's Why You Should Add CLOV Stock to Your Portfolio Now

by Zacks Equity Research

Clover's strong membership growth, rising revenues, and first-half EBITDA profitability highlight its tech-driven Medicare Advantage edge.